Blood Pressure Treatment by the Corsano CardioWatch 287-2 Evaluation Study

Launched by CORSANO HEALTH B.V. · Jul 12, 2024

Keywords

ClinConnect Summary

The Blood Pressure Treatment by the Corsano CardioWatch 287-2 Evaluation Study is looking at a new wearable device called the Corsano CardioWatch 287-2, which can monitor blood pressure over time. This study aims to see how well the device tracks changes in blood pressure after patients start or adjust their blood pressure medications for a period of 28 days. Participants in this trial will be adults aged 18 to 80 who have high blood pressure that isn't well controlled and need treatment changes as directed by their doctor.

If you join the study, you can expect to wear the Corsano CardioWatch 287-2 on your wrist while also having your blood pressure checked with a standard cuff method. The goal is to compare the blood pressure readings from both devices to see if the Corsano CardioWatch is accurate. It's important to note that some people may not be eligible, such as those with certain medical conditions or those who cannot wear the device for physical reasons. This study is currently recruiting participants, and it offers a chance to help improve remote blood pressure monitoring for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • aged between 18 and 80 years old;
• • able to provide consent;
• • untreated or treated for hypertension, with uncontrolled BP and medical indication for antihypertensive drug initiation or uptitration or change in antihypertensive drug per doctor prescription.
• Exclusion Criteria:
• • Unable to wear the Corsano CardioWatch 287 due to reasons such as allergic reactions, wounds, amputations etc.;
• • Unable to receive blood pressure measurements per cuff due to lymphedema, amputation, dialysis shunt, wounds, etc.;
• • Pregnant women;
• • Breastfeeding women;
• • Upper arm circumference not within the cuff range (22-42 cm)
• • Unable or not willing to sign for informed consent;
• • Significant mental or cognitive impairment.